Search Results: PARP

• Health & Medicine
• Science & Technology

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented. One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

9 June 2021

• For Supporters

Catch up on Behind the Science 2021 – From funding stream to blood stream: Is drug development moving fast enough?

This year’s event took place virtually on Wednesday 12 May. Watch or listen back now. This year’s event took place virtually on Wednesday 12 May. Watch or listen back now.

18 May 2021

• Charity News

A tribute to Professor Gordon McVie

Almost 20 years since Cancer Research UK was founded, not many who worked with McVie remain, but staff know him as the man who gave the charity its beginning. Almost 20 years since Cancer Research UK was founded, not many who worked with McVie remain, but staff know him as the man who gave the charity its beginning.

18 February 2021

• Health & Medicine

NICE approves new maintenance treatment for ovarian cancer

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer. A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

19 January 2021

• Science & Technology
• Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021

• Charity News

Cancer Research UK forced to cut research funding due to COVID-19

Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million. Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million.

8 December 2020

• Opinion

Opinion: 'Let’s not be short-sighted – the UK’s medical research charities need urgent support'

Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding. Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.

24 September 2020

• Health & Medicine

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

1 May 2020

• Health & Medicine

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

26 March 2020

• Health & Medicine

Coronavirus and cancer – latest updates

We're pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer. We're pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer.

19 March 2020

• Health & Medicine

Targeted ovarian cancer drug made available to more people on NHS in England

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England. NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

11 December 2019

• Health & Medicine

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy. A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

9 December 2019